Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tulsi Supplementation in Young Overweight and Obese Subjects
NCT02681939Phase 2Completed
- Sponsor
- AIIMS New Delhi
- Start
- Feb 2016
- Primary completion
- Apr 2016
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by AIIMS New Delhi. Primary endpoint: Serum lipid profile at 60 days. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02681939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02681939.